Health Care Industry
Industry: Email Alert RSS FeedShort-Term Cardiovascular Effects of Methylphenidate and Adderall.
Journal of the American Academy of Child and Adolescent Psychiatry, May, 2001 by MANOS, MICHAEL J.
ABSTRACT
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
Objective: The primary purpose of this study was to examine the cardiovascular effects of Adderall [R] (ADL) in a clinic-based group of youths with attention-deficit/hyperactivity disorder ranging in age from 4 to 17 years. Method: One hundred thirty-seven patients were treated with either methylphenidate (MPH) or ADL. Youths prescribed MPH were given medication twice daily, and youths treated with ADL received medication once daily. Patients were evaluated under five conditions: baseline, placebo, 5 mg/dose, 10 mg/dose, or 15 mg/dose. Resting pulse, diastolic blood ...
Read the rest of this article with a Free Trial at HighBeam Research.